Kewaunee Scientific Corporation (Nasdaq: KEQU), a company involved in the design, manufacture, and installation of laboratory, healthcare, and technical furniture products, announced on Friday that it has named David S Rhind as its new chairman of the board of directors.
Rhind succeeds William A Shumaker who served as chairman of the board since 2013 and who resigned effective 31 January 2019.
Rhind has served as a director for the company since 2008 and as chairman of the Nominating and Corporate Governance Committee since June 2011. He is an attorney-at-law who brings to the role of chairman a broad an extensive background in business and legal affairs with global, publicly-traded corporations. He is a member of a founding family involved with Kewaunee since 1906 and he earlier served as deputy general counsel for Hudson Global Inc of New York, New York. He also previously served as general counsel, North America, for Hudson and was associate general counsel at Technology Solutions Company of Chicago. He is a member of the National Association of Corporate Directors.
Nuevocor names new chief medical officer
ELIAS Animal Health names new chief revenue officer
enGene Holdings names new senior vice president, Urologic Oncology and Clinical Development
HealthTrackRx names new chief medical officer
PureTech announces launch of Seaport Therapeutics with USD100m Series A financing
REVIAN names new vice president of Healthcare Sales
Orsini Specialty Pharmacy names new CFO and EVP of Trade Relations and Account Management
Ligand Pharmaceuticals launches Pelthos Therapeutics to drive ZELSUVMI commercialisation
Soligenix announces agreement on design for second Phase 3 trial for HyBryte with EMA
Ratio Therapeutics names new chief business officer and director
Trevi Therapeutics names new vice president of Clinical Development
NeoImmuneTech names new president and chief executive officer